Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023
Webcast Scheduled for Wednesday, August 9, 2023, at 4:30 p.m. EasternSAN DIEGO and GAINESVILLE, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE)…
Pharmaceuticals, Biotechnology and Life Sciences
Webcast Scheduled for Wednesday, August 9, 2023, at 4:30 p.m. EasternSAN DIEGO and GAINESVILLE, Ga., Aug. 02, 2023 (GLOBE NEWSWIRE)…
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical…
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a…
BASEL, Switzerland and LONDON and NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) today announced that it…
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with…
Renowned Jamaican Psilocybin Cultivator and Supplier Expands Operations and Sets Eyes on U.S.RUNAWAY BAY, Jamaica, Aug. 01, 2023 (GLOBE NEWSWIRE)…
DURHAM, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…
Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth Across All…
TORONTO, July 31, 2023 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),…
ROCKVILLE, MD, July 31, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and…